The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey

Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, Loessl K, Pieters B, Rao C, Strnad V, Sturdza AE, Tagliaferri L, Takacsi-Nagy Z, Villafranca E, Wojcieszek P, Rembielak A, Niehoff P (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Book Volume: 50

Article Number: 100883

DOI: 10.1016/j.ctro.2024.100883

Abstract

A survey regarding utilisation of brachytherapy was distributed to European brachytherapy professionals. Eighty replies from 26 countries were received, two of which were outside Europe. The replies showed that brachytherapy is still widely used. The main indications for brachytherapy are gynaecological and prostate cancer, with >80 % of the responding countries performing brachytherapy for these indications. There is on average one brachytherapy centre per 0.8 million inhabitants, ranging from 0.4 per million to 2.3 per million inhabitants. The organisation of brachytherapy on national levels also varies from country to country, with less than half of the countries having a central brachytherapy registry. All in all, the survey shows that brachytherapy still plays a role on modern radiotherapy, but the field could benefit from a stronger collaboration both nationally and internationally.

Authors with CRIS profile

Involved external institutions

Aarhus University Denmark (DK) University Medical Centre Utrecht (UMC Utrecht) Netherlands (NL) Universitätsklinikum Tübingen Germany (DE) Centre Antoine Lacassagne (UNICANCER) France (FR) Medizinische Universität Wien Austria (AT) Fondazione Policlinico Universitario Agostino Gemelli IRCCS Italy (IT) Semmelweis University / Semmelweis Egyetem Hungary (HU) Hospital Universitario de Navarra Spain (ES) Maria Skłodowska-Curie Institute of Oncology / Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie Poland (PL) Christie NHS Foundation Trust United Kingdom (GB) Sana Klinikum Offenbach Germany (DE) Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet Norway (NO) Medical Institute for Radiation Oncology / Insituto Médico de Onco-Radioterapia (IMOR) Spain (ES) Inselspital, Universitätsspital Bern Switzerland (CH) Amsterdam University Medical Centers (Amsterdam UMC) / Amsterdam Universitair Medische Centra Netherlands (NL) Imperial College London / The Imperial College of Science, Technology and Medicine United Kingdom (GB)

How to cite

APA:

Johansen, J.G., Jürgenliemk-Schulz, I.M., Haddad, H., Hannoun-Levi, J.M., Hellebust, T.P., Guix, B.,... Niehoff, P. (2025). The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey. Clinical and Translational Radiation Oncology, 50. https://doi.org/10.1016/j.ctro.2024.100883

MLA:

Johansen, J. G., et al. "The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey." Clinical and Translational Radiation Oncology 50 (2025).

BibTeX: Download